Presenting Companies 2023

Able Innovations is a robotics company solving the problem of staff scarcity and burnout. The ALTA Platform is an intelligent device that enables a single operator to effortlessly transfer patients in and out of bed.

A.i. VALI mission is to improve the quality and accuracy of endoscopic procedures, as well as patients' quality of life, in a more cost-effective and timely manner.

Allarta is a pre-clinical life science company with platform technology to deliver curative cell and stem cell therapies. Allarta combines it’s proprietary immune-privileged polymer platform with proprietary encapsulation to deliver safe, durable, retrievable therapy.

AmacaThera is a clinical-stage biotechnology company transforming therapeutics to make a difference in patient health.

Ankarys is developing scalable and cost-effective stem cell-derived natural killer cell therapies with unique engineered proteins designed to overcome immune inhibition by the tumor microenvironment. 

Avivo is developing a proprietary enzyme system that converts blood-type antigens on human tissue cells to make them type-O, the universal donor type.

Axolotl Biosciences provides turn-key reagents such as functional bioinks, 3D tissue models, and services in the field of 3D bioprinting.

We have developed the world's first blind spot sensors that can transform any wheelchair into a "smart" wheelchair.

Breathe BioMedical is building best in class breath analytics technology to develop accurate, non-invasive breath tests to detect cancer and other diseases.

Developed and commercialized the first and only intracoronary imaging system that combines co-registered ultrasound (IVUS) and optics (OCT).

Personal Pelvic Health: life-changing personalized gynecological devices for women suffering from a common, growing, and underserved health issues.

Cura Therapeutics is developing a first-in-class immunotherapy drug platform to treat a wide range of solid malignancies and infectious diseases.

Derm-Biome is a preclinical biopharmaceutical company focused on developing safe and highly effective topical therapies for the treatment of chronic inflammatory skin diseases and skin cancer.

A digital health company pioneering nicotine addiction treatment with artificial intelligence and a revolutionary device.

Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology.

Developing ultrastable vaccines for emerging infectious disease and pandemic readiness.

Enhanced Medical Nutrition (EMN) builds nutrition products to help patients prepare better and recover faster from surgery.

Endogena Therapeutics is clinical stage biotech company developing endogenous regenerative medicines using AI-driven small molecule design.

Knowledge based computer application to help patients and health care professionals improve the history taking process.

Fluid Biomed is a VC-backed, pre-clinical, and seed-stage medical device startup, that is developing the world’s first polymer-based stent to cure brain aneurysms.

Fluid is developing a smart post-operative monitoring system to detect early signs of anastomotic (gastrointestinal) leakage, enabling improved patient recovery with data-driven intervention.

Validated, late stage point of care molecular diagnostic company focused on genotype guided precision medicine and open platform partnerships for adjacent verticals of infectious disease, animal diagnostics and food safety, now entering high growth commercialization.

Gotcare is a national health tech provider transforming what it means to receive healthcare in the home.

Hemostemix is a clinical-stage biotechnology company focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases.

Hyivy Health creates data driven pelvic rehabilitation system for the 1 in 3 women worldwide who will experience a pelvic health complication in their lifetime.

Connect with your healthcare colleagues through real-time scheduling, on-call management, and secure messaging on any device; in over 100 facilities.

We are creating life-saving gene therapies for monogenic lung diseases with the potential to extend the application to acquired lung diseases.

Cell therapy company focused on solving currently incurable conditions of the Central Nervous System.

Jenthera develops a novel and proprietary gene editing platform that directly delivers the CRISPR RNP, resolving the critical limitations of current gene editing systems and aiming to unlock new therapeutic avenues.

Experienced development team working in close collaboration with NRC-HHT to bring proprietary ACE2-Fc biological to patients for clinical testing and approval in acute respiratory and kidney injury.

JVP Labs is a Congestive Heart Failure (CHF) remote patient monitoring start-up. Our single device provides automated, hospital quality vital sign work up, including Jugular Venous Pressure (JVP) height, in less than 1 minute a read. The system is non invasive, cost effective and easily deployed by elderly patients.

KEEP Labs is a Remote Therapeutic Monitoring (RTM) platform optimizing the specialty medication experience in the home.

Mediphage is developing safe and re-dosable non-viral gene therapies based on its proprietary ministring DNA (msDNA) technology.

Micellae is commercialising a revolutionary drug delivery formulation platform which significantly enhances the solubility, bioavailability, potency, and time to onset of action of cannabinoids and other fat-soluble compounds.

MACH32's novel drug delivery platform is revolutionizing pre-hospital trauma care in order to stop patients from bleeding to death.

MISO Chip develops predictive assays to stratify responding and resistant patients to specific cancer treatments before any treatment is given.

Noa Therapeutics (Noa) is a preclinical Canadian biotech company on a mission to remove complexity from patients' lives by streamlining treatment of inflammatory skin diseases with our novel, multimodal therapeutics.

We develop a medical device that generates highly reactive gaseous chemicals that kill cancer cells in the tumor bed after a solid tumor is removed to reduce cancer recurrence.

20/20 OptimEyes Technologies is a pre-clinical biotechnology company commercializing a drug delivery formulation to improve ocular therapies treated with eye drops, including glaucoma and dry eye disease.

Panaxium is developing a novel bioelectronic device therapy, to help the millions of people recover from their disability following a stroke.

Paradox Immunotherapeutics is an orphan drug platform company developing immunotherapies for protein misfolding diseases.

Primary Peptides is a clinical stage biotechnology company, pioneering new peptide therapeutics for patients with neurological disorders by expanding the pool of undruggable targets using protein manipulation.

We use computational tools to enable peptide ligands which are 100x more drug-like and specific than natural ligands. This enables the next generation of therapeutic applications with a focus on next generation therapeutic payloads (nucleotides, siRNA, radioisotopes, etc.) delivered with de-novo peptides.

QurCan Therapeutics has developed a novel drug delivery "TERP" that enables safe and site-specific delivery of therapeutics, and has a lead asset in pipeline that overcomes the treatment-resistance in tumor microenvironment.

Rehabtronics has developed the world's first neuromodulation-based technology for early intervention of pressure injuries, one of healthcare's most common, expensive and deadly medical complications.

RetiSpec leverages retinal imaging and AI to enable point-of-care Alzheimer’s disease detection in the community.

Ripple Therapeutics is a clinical stage company focused on improving ophthalmic therapeutics with controllable, sustained drug delivery.

Rostrum Medical has developed a game changing technology to non-invasively support individualized patient care for mechanically ventilated patients.

Accelerated tissue regeneration and wound healing via target immunomodulation with a topically applied, DNA-based platform technology.

Sustained Therapeutics is a clinical stage company utilizing its advanced clinical and research expertise to develop locally injected, sustained-release therapeutics primarily for the treatment of pain and urologic diseases.

Synaptive is a Toronto-based medical device company with a suite of surgical products (planning, navigation, microscope) and small foot-print MRI.

Targa is a clinically focused biotechnology company possessing key pharmacological assets that increase the manufacturing quality and therapeutic impact of cell therapy and opportunities for organ transplantation.

TATUM bioscience develops revolutionary multipronged immunotherapies for oncology.

ClearToe Therapy is safe, non-toxic and a simple treatment that can be administered in 30 minutes. Our technology is designed to clear up the yellow, crumbling appearance of toenail fungus (onychomycosis).

A vaccine company using proprietary 1c-SApNP® Nanoparticle platform technology to develop and commercialize prophylactic vaccines for the most challenging infectious disease.

We use generative AI to create molecules the world has never seen before that become better medicines faster than ever.

Vena Medical is providing physicians with the world's smallest camera capable of going inside veins and arteries to help them treat stroke.

The first affordable, high quality blood analyzer with disposable test chips for home use.

Xpan develops smaller and expandable tubular access devices targeted at making minimally invasive procedures safer and efficient.

Zilia is developing groundbreaking technology bound to redefine the way we prevent, diagnose, and treat various ocular, neurological, and systemic conditions.